CorMedix (CRMD) Change in Cash (2010 - 2025)

CorMedix has reported Change in Cash for 15 years, with the latest figure at $96.3 million in Q4 2025.

• Quarterly Change in Cash rose 1695.79% year-over-year to $96.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $105.1 million (up 3525.79% YoY) and the FY2025 annual result came in at $105.1 million, up 3525.79% from the prior year.
• Change in Cash improved to $96.3 million in Q4 2025 per CRMD's latest filing, from -$109.9 million in the prior quarter.
• Over five years, Change in Cash peaked at $96.3 million in Q4 2025 and troughed at -$109.9 million in Q3 2025.
• A 5-year average of $5.2 million and a median of -$4.4 million in 2021 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2023 and 2025: Change in Cash plunged 10051.5% in 2023, then soared 1695.79% in 2025.
• Over 5 years, Change in Cash stood at -$13.0 million in 2021, then soared by 99.27% to -$95334.0 in 2022, then slumped by 10051.5% to -$9.7 million in 2023, then jumped by 155.44% to $5.4 million in 2024, then jumped by 1695.79% to $96.3 million in 2025.
• According to Business Quant data, Change in Cash over the past three periods registered $96.3 million, -$109.9 million, and $93.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.